Hepatitis Delta Book Rizetto

The Revised Authoritative Guide To Vaccine Legal Exemptions

Vaccines Have Serious Side Effects

Get Instant Access

Hepatitis delta virus (HDV) has been recognized to be an important cause of acute or chronic hepatitis in humans. HDV infection may occur as coin-fection with hepatitis B virus (HBV) or as superinfection of a chronically HBV-infected patient (Rizetto et al. 1984). The course of simultaneous infection is similar to HBV infection alone and clearance of HBV is accompanied by elimination of HDV. HDV superinfection of chronically HBV-infected patients results in chronic HDV infection in more than 80% of cases. This often progresses rapidly to liver cirrhosis and hepatocellular carcinoma (Fattovich etal. 1987).

The immunopathogenesis of HDV infection has not been investigated in detail so far. Antibodies recognizing both HDV proteins are detected at low titers during acute infection and reach high levels during chronic infection, but are not able to modulate the course of infection. Therefore, antibodies are probably not able to neutralize the virus (Rizetto 1981, 1984). The predictive role of antibodies of the IgM-class for the course of HDV infection has been studied extensively and is somewhat controversial (Aragona et al. 1987; Borghesio et al. 1998; Farci et al. 1986; Govindarajan et al. 1989). Several groups investigated the fine specificity of the antibody response and defined immunogenic epitopes (Bergmann et al. 1989; Seizer et al. 2005; Wang et al. 1990). Knowledge of the cellular immune response in HDV infection is still incomplete. A polyspecific, but weak T helper (Th) cell response is observed in patients with acute self-limiting HDV infection, but is absent in chronically HDV-infected patients (Nisini et al. 1997). The liver damage results in serum alanine and aspartate aminotransferase (ALT and AST) elevation. This observation, as well as the fact that HDV itself is not cytopathic (Guilhot et al. 1994), may indicate that cytotoxic T cells (CTL) are responsible for destruction of hepatocytes; however, little is known about the CTL response in HDV infection. Recently, Huang et al. identified two HLA-A*0201-restricted CD8+ T-cell epitopes on HDV (Huang et al. 2004).

Vaccination studies might also give insight into the role of the immune response in HDV infection. Woodchucks chronically infected with woodchuck hepatitis virus (WHV) can be superinfected with HDV and therefore can be a good model to test vaccine candidates. Different strategies have been investigated to establish a protective vaccine against HDV superinfection. Synthetic peptides, HDAg expressed in Escherichia coli, yeast, or baculovirus, infection with vaccinia virus expressing the small or the large hepatitis delta antigen (S-HDAg, L-HDAg), and DNA immunization by gene gun have been studied. So far, none of these protocols has been able to protect woodchucks from HDV superinfection, but in some studies a modulation of the course of infection was observed (see Sects. 4.1-4.6).

The current knowledge about the B- and T-cell immune responses in HDV infection and an update of vaccine trials will be covered in this review.

Was this article helpful?

0 0
How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book

Post a comment